US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

KraneShares MSCI All China Health Care Index ETF

18.91

+0.25501.37%

Post-market: 18.910.00000.00%16:10 EDT

Volume:10.43K

Turnover:195.98K

Market Cap:109.70M

PE:- -

High:18.91

Open:18.83

Low:18.67

Close:18.66

52wk High:21.88

52wk Low:14.38

Shares:5.80M

Float Shares:5.80M

Volume Ratio:0.35

T/O Rate:0.18%

Dividend:0.71

Dividend Rate:3.78%

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Akeso Says China NMPA Approves Ivonescimab Plus Chemo for First-Line Squamous NSCLC

CSPC Pharmaceutical Receives USD 30 Million Upfront Payment from AstraZeneca Under siRNA Pact

Akeso - China Nmpa Approves Ivonescimab Plus Chemotherapy for First-Line Advanced Squamous Nsclc

THOMSON REUTERS

CSPC Pharmaceutical - Receives US$30 Mln Upfront Payment from AstraZeneca on Aug 12 2026 Under Collaboration Agreement

THOMSON REUTERS

CSPC Pharma Starts Phase 1 Trial of CAR-T Drug for Relapsed, Refractory Lupus

MT Newswires Live

Akeso (SEHK:9926) Could Be 41% Undervalued On Phase II Breast Cancer Trial Progress

Simply Wall St.

CSPC Pharma's SYS 6063 Trial for Lupus Clears First Site in China

CSPC Pharmaceutical - Pharma Initiates Phase I Trial of Sys6063 for Relapsed, Refractory Sle in China

THOMSON REUTERS

Pharmaceutical Rally Continues: Gan&Lee Pharmaceuticals Hits Limit-Up, Beone Medicines Logs 6-Day Winning Streak; Huabao Funds' HK Medical and Innovation Drug ETFs Rise for Third Consecutive Session

CICC Retains Outperform Rating on BeiGene (06160) with HKD 266 Price Target

BEONE MEDICINES Surges Over 4% in Morning Trading on Strategic Partnership with Revolution Medicines to Accelerate RAS Drug Development

CSPC Pharmaceutical's Mpox Vaccine Candidate Gets Trial Approval from US FDA

MT Newswires Live

CSPC Pharma (01093) Receives FDA Clearance for US Clinical Trial of Monkeypox mRNA Vaccine

CSPC Says FDA Clears US Clinical Trial for SYS 6037 Mpox mRNA Vaccine

CSPC Pharmaceutical - Sys6037 Mpox Mrna Vaccine Obtains FDA Clinical Trial Approval in U.S.

THOMSON REUTERS

Innovent Biologics Schedules Board Meeting to Review Interim Results

Innovent Biologics Slashes Prices on Weight-Loss Drug as Growth Concerns Mount

Akeso Doses First Patient in Phase II Trial of Ak146d1 ADC Plus Ivonescimab in Advanced Breast Cancer

Akeso Advances IO2.0 + Adc2.0 Strategy: First Patient Dosed in Phase Ii Study of Trop2/Nectin-4 Bispecific ADC (Ak146d1) Combined with Ivonescimab in Breast Cancer

THOMSON REUTERS

BOCOM International Lifts BEONE MEDICINES Price Target to HKD 276, Maintains Buy Rating

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://au1.tigerplaytime.com/stock/KURE/news?page=10"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"KURE","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"KURE\",,,,,undefined,":{"symbol":"KURE","market":"US","secType":"STK","nameCN":"KraneShares MSCI All China Health Care Index ETF","latestPrice":18.91,"timestamp":1788465600000,"preClose":18.655,"halted":0,"volume":10429,"hourTrading":{"tag":"盘后","latestPrice":18.91,"preClose":18.91,"latestTime":"16:10 EDT","volume":10,"amount":189.1,"timestamp":1788466205561,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":0.013669257571696541,"floatShares":5800979,"shares":5800979,"eps":0,"marketStatus":"Post-Mkt","change":0.255,"latestTime":"09-03 17:09:29 EDT","open":18.83,"high":18.91,"low":18.6655,"amount":195976,"amplitude":0.013106,"askPrice":20.61,"askSize":100,"bidPrice":17.09,"bidSize":100,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":3,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1788480000000},"marketStatusCode":4,"adr":0,"adrRate":0,"exchange":"ARCA","adjPreClose":18.655,"sharesOutstanding":4750002,"nav":18.46,"aum":108936686.05,"dividendRate":0.0378,"bidAskSpread":0.00342,"postHourTrading":{"tag":"盘后","latestPrice":18.91,"preClose":18.91,"latestTime":"16:10 EDT","volume":10,"amount":189.1,"timestamp":1788466205561,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.349371,"impliedVol":0.2767,"impliedVolPercentile":0.5754},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"KURE\",,,,,undefined,":{"symbol":"KURE","floatShares":5800979,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.349371,"shares":5800979,"dividePrice":0.7148,"high":18.91,"amplitude":0.013106,"preClose":18.655,"low":18.6655,"week52Low":14.3797,"pbRate":"--","week52High":21.875,"institutionHeld":0,"latestPrice":18.91,"eps":0,"divideRate":0.0378,"volume":10429,"delay":0,"ttmEps":0,"open":18.83,"prevYearClose":17.04,"prevWeekClose":18.925,"prevMonthClose":18.54,"prevQuarterClose":15.747,"fiveDayClose":19.215,"twentyDayClose":17.47,"sixtyDayClose":14.5156},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/KURE\",params:#limit:5,,,undefined,":[{"date":"2025-12-22","symbol":"KURE","amount":0.714689,"announcedDate":"2025-12-19","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-22","defaultRemindTime":1766413800000,"name":"KraneShares MSCI All China Health Care Index ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-23","payableDate":"2025-12-22","currency":"USD","dateTimestamp":1766379600000,"payDate":"2025-12-23"},{"date":"2024-12-17","symbol":"KURE","amount":0.18361,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-12-17","defaultRemindTime":1734445800000,"name":"KraneShares MSCI All China Health Care Index ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-12-18","payableDate":"2024-12-17","currency":"USD","dateTimestamp":1734411600000,"payDate":"2024-12-18"},{"date":"2023-12-18","symbol":"KURE","amount":0.112844,"announcedDate":"2023-12-15","type":"dividend","market":"US","newRecordDate":"2023-12-19","defaultRemindTime":1702909800000,"name":"KraneShares MSCI All China Health Care Index ETF","recordDate":"2023-12-20","payableDate":"2023-12-19","currency":"USD","dateTimestamp":1702875600000,"payDate":"2023-12-20"},{"market":"US","date":"2022-12-28","symbol":"KURE","amount":0.010399,"defaultRemindTime":1672237800000,"name":"KraneShares MSCI All China Health Care Index ETF","recordDate":"2022-12-30","payableDate":"2022-12-29","currency":"USD","type":"dividend","dateTimestamp":1672203600000},{"market":"US","date":"2021-12-29","symbol":"KURE","amount":4.053448,"defaultRemindTime":1640788200000,"name":"KraneShares MSCI All China Health Care Index ETF","recordDate":"2021-12-31","payableDate":"2021-12-30","currency":"USD","type":"dividend","dateTimestamp":1640754000000}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"KURE\",market:\"US\",,,undefined,":[{"executeDate":"2018-12-26","recordDate":"2018-12-27","paymentDate":"2018-12-28","value":0.039344,"currency":"USD"},{"executeDate":"2019-12-27","recordDate":"2019-12-30","paymentDate":"2019-12-31","value":0.057325,"currency":"USD"},{"executeDate":"2020-12-29","recordDate":"2020-12-30","paymentDate":"2020-12-31","value":0.000109,"currency":"USD"},{"executeDate":"2021-12-29","recordDate":"2021-12-30","paymentDate":"2021-12-31","value":4.053448,"currency":"USD"},{"executeDate":"2022-12-28","recordDate":"2022-12-29","paymentDate":"2022-12-30","value":0.010399,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"KURE\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"KURE\",pageSize:20,pageCount:10,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2658972050","title":"Akeso Says China NMPA Approves Ivonescimab Plus Chemo for First-Line Squamous NSCLC","url":"https://stock-news.laohu8.com/highlight/detail?id=2658972050","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658972050?lang=en_us&edition=fundamental","pubTime":"2026-08-12 20:22","pubTimestamp":1786537330,"startTime":"0","endTime":"0","summary":"Akeso says China NMPA approves ivonescimab plus chemo for first-line squamous NSCLCChina’s NMPA cleared ivonescimab with chemotherapy for first-line advanced squamous non-small cell lung cancer.Phase ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260812:nNDL7SlDKQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B5MMRT66.SGD","LU0348783233.USD","LU2399975544.HKD","IE00B543WZ88.USD","LU0348784397.USD","LU0540923850.HKD","LU0561508036.HKD","LU1720050803.USD","LU2778985437.USD","LU0417516738.SGD","LU2488822045.USD","LU0417516902.SGD","LU0348766576.USD","BK1161","BK1574","LU0348825331.USD","LU2476274308.USD","IE00BPRC5H50.USD","LU1961090484.USD","LU0348767384.USD","LU0348827113.USD","LU2476274720.SGD","KURE","LU0348735423.USD","LU0634319403.HKD","LU0417516571.SGD","09926","LU1794554557.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658972766","title":"CSPC Pharmaceutical Receives USD 30 Million Upfront Payment from AstraZeneca Under siRNA Pact","url":"https://stock-news.laohu8.com/highlight/detail?id=2658972766","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658972766?lang=en_us&edition=fundamental","pubTime":"2026-08-12 20:19","pubTimestamp":1786537140,"startTime":"0","endTime":"0","summary":"CSPC Pharmaceutical receives USD 30 million upfront payment from AstraZeneca under siRNA pactCSPC received a USD 30 million upfront payment from AstraZeneca on Aug. 12 under an siRNA collaboration, op","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260812:nNDL8LP9ZV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1003076772.USD","BK1191","KURE","LU0553294199.USD","01093","AZN.UK","LU1008478684.HKD","LU0171276677.USD","LU1481600234.SGD","BK5011","SG9999001176.SGD","03165","LU0140636845.USD","LU1226288170.HKD","LU1863844749.USD","LU2237443978.SGD","LU1923622614.USD","LU1993786604.SGD","LU0047473722.EUR","LU0314109678.HKD","LU0661504455.SGD","LU0823399737.USD","LU0501845795.SGD","LU2293690249.USD","IE00B543WZ88.USD","LU0310800379.SGD","BK1521","IE00BFTCPJ56.SGD","LU2237443622.USD","LU1273509221.SGD","LU1355424745.HKD","IE00B2B36J28.USD","LU0757432116.USD","LU0827474353.SGD","SG9999004220.SGD","LU0052756011.USD","LU2125909247.SGD","LU0889566641.SGD","LU0887340254.USD","LU1019632923.USD","LU0880133367.SGD","LU0640478417.SGD","LU1064927863.SGD","LU0969580561.USD","LU1061106388.HKD","LU1328277881.USD","LU0203345920.USD","LU0882574055.USD","LU1481599808.USD","LU0920840948.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658997273","title":"Akeso - China Nmpa Approves Ivonescimab Plus Chemotherapy for First-Line Advanced Squamous Nsclc","url":"https://stock-news.laohu8.com/highlight/detail?id=2658997273","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658997273?lang=en_us&edition=fundamental","pubTime":"2026-08-12 20:18","pubTimestamp":1786537113,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260812:nFWN44916C:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU2476274308.USD","IE00B5MMRT66.SGD","KURE","LU0348735423.USD","BK1161","LU1794554557.SGD","LU0348825331.USD","LU2778985437.USD","09926","LU0348784397.USD","LU1720050803.USD","LU0348766576.USD","LU0348767384.USD","IE00B543WZ88.USD","LU2399975544.HKD","BK1574","LU0348783233.USD","LU2476274720.SGD","LU0417516738.SGD","LU0634319403.HKD","LU2488822045.USD","LU1961090484.USD","IE00BPRC5H50.USD","LU0540923850.HKD","LU0417516902.SGD","LU0417516571.SGD","LU0561508036.HKD","LU0348827113.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658722729","title":"CSPC Pharmaceutical - Receives US$30 Mln Upfront Payment from AstraZeneca on Aug 12 2026 Under Collaboration Agreement","url":"https://stock-news.laohu8.com/highlight/detail?id=2658722729","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658722729?lang=en_us&edition=fundamental","pubTime":"2026-08-12 20:17","pubTimestamp":1786537031,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260812:nFWN4490RL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU1226287875.USD","IE00BZ08YT58.USD","LU1152091754.HKD","LU1813983027.USD","LU2039709279.SGD","LU0067412154.USD","BK1191","KURE","LU1328277881.USD","IE00BZ08YR35.GBP","IE00B543WZ88.USD","LU0315179316.USD","LU0072913022.USD","LU0880133367.SGD","LU1226288253.USD","IE00B5MMRT66.SGD","LU1226287529.USD","BK1521","LU1152091168.USD","LU1226287792.SGD","LU1951186391.HKD","IE0008368742.USD","LU1960683339.HKD","LU1226288170.HKD","IE0008369823.USD","LU0326950275.SGD","HK0000165453.HKD","LU1993786604.SGD","LU0314109678.HKD","01093","IE00BZ08YS42.EUR","LU0501845795.SGD","LU1807302812.USD","BK1515","SG9999004220.SGD","IE00B031HY20.USD","LU1008478684.HKD","LU0140636845.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658942043","title":"CSPC Pharma Starts Phase 1 Trial of CAR-T Drug for Relapsed, Refractory Lupus","url":"https://stock-news.laohu8.com/highlight/detail?id=2658942043","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658942043?lang=en_us&edition=fundamental","pubTime":"2026-08-12 09:23","pubTimestamp":1786497820,"startTime":"0","endTime":"0","summary":"CSPC Pharmaceutical (HKG:1093) said Phase 1 clinical trial of its SYS6063 CAR-T therapy for relapsed/refractory systemic lupus erythematosus has begun at its first clinical center in China, according ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK1515","LU1807302812.USD","IE00BZ08YR35.GBP","LU1152091754.HKD","LU1226288170.HKD","HK0000165453.HKD","IE0008368742.USD","LU2039709279.SGD","01093","LU1152091168.USD","LU1813983027.USD","IE00B031HY20.USD","LU0314109678.HKD","IE00B5MMRT66.SGD","IE00BZ08YS42.EUR","LU1226288253.USD","LU1951186391.HKD","CAR","BK4230","LU1008478684.HKD","LU0501845795.SGD","IE0008369823.USD","LU1993786604.SGD","LU1226287529.USD","BK1191","BK1521","LU0326950275.SGD","LU0072913022.USD","LU0140636845.USD","LU0880133367.SGD","SG9999004220.SGD","LU0315179316.USD","LU1328277881.USD","LU1960683339.HKD","BK4022","IE00BZ08YT58.USD","KURE","LU1226287875.USD","LU1226287792.SGD","IE00B543WZ88.USD","LU0067412154.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658914838","title":"Akeso (SEHK:9926) Could Be 41% Undervalued On Phase II Breast Cancer Trial Progress","url":"https://stock-news.laohu8.com/highlight/detail?id=2658914838","media":"Simply Wall St.","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658914838?lang=en_us&edition=fundamental","pubTime":"2026-08-11 20:28","pubTimestamp":1786451296,"startTime":"0","endTime":"0","summary":"Akeso (SEHK:9926) has just reached a fresh clinical milestone. The company has dosed the first patient in a Phase II trial of its TROP2/Nectin-4 ADC AK146D1 in combination with ivonescimab for advanced breast cancer.\nSee our latest analysis for Akeso.\nAkeso's latest trial update comes after a mixed period for the stock, with a 7 day share price return of 8.58% and a 30 day share price return of 4.78%, but a 90 day share price return that declined 19.95%. Over longer horizons, total...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-9926/akeso-shares/news/akeso-sehk9926-could-be-41-undervalued-on-phase-ii-breast-ca","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-9926/akeso-shares/news/akeso-sehk9926-could-be-41-undervalued-on-phase-ii-breast-ca","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["LU2065732104.USD","LU0417516738.SGD","09926","LU0348735423.USD","BK1574","LU1720050803.USD","LU0348825331.USD","LU1794554557.SGD","LU2778985437.USD","LU0348767384.USD","LU1961090484.USD","BK1161","LU0417516571.SGD","LU2476274720.SGD","IE00BPRC5H50.USD","IE00B5MMRT66.SGD","LU0348766576.USD","LU2399975544.HKD","KURE","BK4097","LU0348827113.USD","LU0348783233.USD","LU0348784397.USD","LU0634319403.HKD","IE00B543WZ88.USD","LU0561508036.HKD","LU2488822045.USD","LU2476274308.USD","LU0417516902.SGD","PRGS","LU0540923850.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1103582360","title":"CSPC Pharma's SYS 6063 Trial for Lupus Clears First Site in China","url":"https://stock-news.laohu8.com/highlight/detail?id=1103582360","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1103582360?lang=en_us&edition=fundamental","pubTime":"2026-08-11 20:09","pubTimestamp":1786450140,"startTime":"0","endTime":"0","summary":"CSPC PHARMA (01093) has announced that the Phase I clinical trial of its investigational therapy, SYS 6063, for refractory systemic lupus erythematosus (SLE) has officially commenced at the first...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1191","IBBQ","LU1226287875.USD","LU1328277881.USD","LU1813983027.USD","IE0008369823.USD","IE0008368742.USD","LU1226287529.USD","LU0326950275.SGD","LU0315179316.USD","SG9999004220.SGD","LU1960683339.HKD","LU0314109678.HKD","BK1515","LU1008478684.HKD","LU1807302812.USD","LU0140636845.USD","KURE","LU1951186391.HKD","IE00BZ08YR35.GBP","IE00B543WZ88.USD","LU1226288253.USD","LU1152091168.USD","IE00BZ08YT58.USD","LU0501845795.SGD","LU1152091754.HKD","LU1993786604.SGD","BMED","IE00B031HY20.USD","LU0072913022.USD","LU0067412154.USD","LU1226287792.SGD","IE00BZ08YS42.EUR","PSYK","LU1226288170.HKD","BK1521","HK0000165453.HKD","IBBJ","LU2039709279.SGD","LU0880133367.SGD","MDTX","IE00B5MMRT66.SGD","01093"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658990824","title":"CSPC Pharmaceutical - Pharma Initiates Phase I Trial of Sys6063 for Relapsed, Refractory Sle in China","url":"https://stock-news.laohu8.com/highlight/detail?id=2658990824","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658990824?lang=en_us&edition=fundamental","pubTime":"2026-08-11 20:02","pubTimestamp":1786449766,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260811:nFWN4480FM:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU1008478684.HKD","LU0314109678.HKD","LU0880133367.SGD","LU1152091168.USD","LU1226287529.USD","IE00B031HY20.USD","IE00BZ08YS42.EUR","IE00BZ08YT58.USD","IE00B5MMRT66.SGD","LU1813983027.USD","IE00BZ08YR35.GBP","BK1191","LU0501845795.SGD","LU1328277881.USD","BK1521","LU0315179316.USD","IE00B543WZ88.USD","LU1226288253.USD","HK0000165453.HKD","LU1951186391.HKD","LU1960683339.HKD","LU1226288170.HKD","LU0140636845.USD","LU1152091754.HKD","LU1226287792.SGD","LU0326950275.SGD","LU1993786604.SGD","IE0008368742.USD","LU1226287875.USD","BK1515","SG9999004220.SGD","LU0067412154.USD","KURE","IE0008369823.USD","LU0072913022.USD","LU2039709279.SGD","LU1807302812.USD","01093"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1160122906","title":"Pharmaceutical Rally Continues: Gan&Lee Pharmaceuticals Hits Limit-Up, Beone Medicines Logs 6-Day Winning Streak; Huabao Funds' HK Medical and Innovation Drug ETFs Rise for Third Consecutive Session","url":"https://stock-news.laohu8.com/highlight/detail?id=1160122906","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1160122906?lang=en_us&edition=fundamental","pubTime":"2026-08-11 19:30","pubTimestamp":1786447849,"startTime":"0","endTime":"0","summary":"On August 11, A-shares and Hong Kong stocks experienced a significant pullback, with healthcare assets broadly peaking and then retreating due to overall market conditions. However, the innovative...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["603087","BK1500","LU0588546209.SGD","LU0228659784.USD","BK1588","BK1583","LU1303224171.USD","06160","159316","LU1969619763.USD","LU2328871848.SGD","LU1719994722.HKD","LU1251922891.USD","BK4588","BK0239","159828","BK4585","BK1161","ONC","688235","LU1770034418.SGD","BK4139","LU0307460666.USD","LU0828237510.HKD","KURE","BK4526","FLHK"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1171969636","title":"CICC Retains Outperform Rating on BeiGene (06160) with HKD 266 Price Target","url":"https://stock-news.laohu8.com/highlight/detail?id=1171969636","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1171969636?lang=en_us&edition=fundamental","pubTime":"2026-08-11 09:50","pubTimestamp":1786413022,"startTime":"0","endTime":"0","summary":"CICC has released a research report stating that it maintains its earnings forecasts for BeiGene (06160) for 2026 and 2027. The firm retains an Outperform industry rating and, based on a DCF model,...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["688235","BK4588","LU0588546209.SGD","BK1583","BK4585","LU1251922891.USD","LU1969619763.USD","LU0228659784.USD","LU1303224171.USD","LU1719994722.HKD","ONC","BK1161","KURE","LU0828237510.HKD","06160","BK0239","LU0307460666.USD","LU1770034418.SGD","BK4139","BK1500","EWH","BK1588","BK4526","LU2328871848.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1123475942","title":"BEONE MEDICINES Surges Over 4% in Morning Trading on Strategic Partnership with Revolution Medicines to Accelerate RAS Drug Development","url":"https://stock-news.laohu8.com/highlight/detail?id=1123475942","media":"Stock News","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1123475942?lang=en_us&edition=fundamental","pubTime":"2026-08-11 09:46","pubTimestamp":1786412777,"startTime":"0","endTime":"0","summary":"BEONE MEDICINES (06160) saw its shares surge more than 4% during early trading hours, before settling at a 2.72% gain to 219 Hong Kong dollars, with a trading volume of 297 million Hong Kong...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1583","IE00BFTCPJ56.SGD","BK4139","LU2328871848.SGD","PTH","RVMD","LU1251922891.USD","LU1770034418.SGD","LU0588546209.SGD","LU0109394709.USD","IE0002141913.USD","KURE","IE0009355771.USD","BK1161","LU1969619763.USD","BK4588","LU0889565916.HKD","VXUS","BK0239","IDNA","06160","BK4585","IE00BJT1NW94.SGD","LU1719994722.HKD","LU1303224171.USD","LU0228659784.USD","IE00B2B36J28.USD","IE0009354923.USD","BK1500","688235","BBH","BK4526","BK1588","CANC","LU0307460666.USD","LU0828237510.HKD","LU0320765992.SGD","ONC","KCAI","IE00B4R5TH58.HKD","IE00BJJMRZ35.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658933761","title":"CSPC Pharmaceutical's Mpox Vaccine Candidate Gets Trial Approval from US FDA","url":"https://stock-news.laohu8.com/highlight/detail?id=2658933761","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658933761?lang=en_us&edition=fundamental","pubTime":"2026-08-10 19:40","pubTimestamp":1786362027,"startTime":"0","endTime":"0","summary":"CSPC Pharmaceutical's  SYS6037 Injection obtained approval from the U.S. Food and Drug Administration  to conduct clinical trials in the U.S.The mpox vaccine was co-developed by the company and the Institute of Microbiology, the Chinese Academy of Sciences, according to a Monday Hong Kong bourse filing.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU0326950275.SGD","SG9999004220.SGD","BK1521","KURE","BK4588","LU1226288253.USD","LU1328277881.USD","IE00B031HY20.USD","01093","HK0000165453.HKD","BK1515","LU1226287792.SGD","IE00B5MMRT66.SGD","IE00BZ08YT58.USD","IE0008368742.USD","LU0314109678.HKD","LU1951186391.HKD","LU0072913022.USD","LU1226288170.HKD","LU1152091168.USD","LU1960683339.HKD","LU0315179316.USD","IE00BZ08YS42.EUR","LU0067412154.USD","LU0140636845.USD","LU0501845795.SGD","IE00B543WZ88.USD","LU1807302812.USD","LU1152091754.HKD","LABU","LU1226287529.USD","BK4585","BK1191","LU1813983027.USD","IE0008369823.USD","LU1226287875.USD","IE00BZ08YR35.GBP","LU0880133367.SGD","LU1008478684.HKD","LU1993786604.SGD","LU2039709279.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1182339913","title":"CSPC Pharma (01093) Receives FDA Clearance for US Clinical Trial of Monkeypox mRNA Vaccine","url":"https://stock-news.laohu8.com/highlight/detail?id=1182339913","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1182339913?lang=en_us&edition=fundamental","pubTime":"2026-08-10 19:02","pubTimestamp":1786359759,"startTime":"0","endTime":"0","summary":"CSPC Pharma (01093) announced that its investigational new drug, SYS 6037 injection (monkeypox mRNA vaccine), a Class 1 preventive biological product developed in collaboration with the Institute of...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0067412154.USD","LU0326950275.SGD","IBBQ","BK4139","IE0008368742.USD","LU2039709279.SGD","BK4505","LU1226288170.HKD","SG9999004220.SGD","LU0140636845.USD","IE00B5MMRT66.SGD","01093","BMED","IE00BZ08YS42.EUR","KURE","LU1328277881.USD","LU0072913022.USD","LU0314109678.HKD","LU1152091754.HKD","PSYK","BK4588","LU1008478684.HKD","LU1226287529.USD","LU1807302812.USD","BK1515","BK1191","LU0880133367.SGD","LU1226287792.SGD","LU1951186391.HKD","IE00B543WZ88.USD","RNA","IE00B031HY20.USD","159646","LU1813983027.USD","BK4585","LU1152091168.USD","BK1521","IE0009354923.USD","LU1226287875.USD","HK0000165453.HKD","LU1960683339.HKD","LU1226288253.USD","LU0501845795.SGD","IE0008369823.USD","IE00BZ08YT58.USD","LU1993786604.SGD","MDTX","IE00BZ08YR35.GBP","IBBJ","LU0315179316.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658270980","title":"CSPC Says FDA Clears US Clinical Trial for SYS 6037 Mpox mRNA Vaccine","url":"https://stock-news.laohu8.com/highlight/detail?id=2658270980","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658270980?lang=en_us&edition=fundamental","pubTime":"2026-08-10 18:58","pubTimestamp":1786359481,"startTime":"0","endTime":"0","summary":"CSPC says FDA clears US clinical trial for SYS 6037 mpox mRNA vaccineCSPC’s SYS 6037 injection, an mRNA monkeypox vaccine co-developed with the Chinese Academy of Sciences’ Institute of Microbiology, ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260810:nNDL4XF0Px:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0315179316.USD","LU0067412154.USD","LU1951186391.HKD","LU1226287529.USD","LU1226288253.USD","LU2039709279.SGD","LU1008478684.HKD","LU1993786604.SGD","LU0314109678.HKD","SG9999004220.SGD","LU1807302812.USD","LU1226287875.USD","IE00BZ08YT58.USD","IE0008368742.USD","LU1960683339.HKD","BK1521","LU0326950275.SGD","BK1515","LU1328277881.USD","BK1191","LU1226287792.SGD","LU0072913022.USD","LU1152091168.USD","IE00B5MMRT66.SGD","IE00B543WZ88.USD","LU0880133367.SGD","HK0000165453.HKD","LU1226288170.HKD","LU1813983027.USD","LU1152091754.HKD","LU0140636845.USD","IE00BZ08YR35.GBP","IE00BZ08YS42.EUR","01093","IE0008369823.USD","IE00B031HY20.USD","KURE","LU0501845795.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658980216","title":"CSPC Pharmaceutical - Sys6037 Mpox Mrna Vaccine Obtains FDA Clinical Trial Approval in U.S.","url":"https://stock-news.laohu8.com/highlight/detail?id=2658980216","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658980216?lang=en_us&edition=fundamental","pubTime":"2026-08-10 18:57","pubTimestamp":1786359457,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260810:nFWN4470EH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU0072913022.USD","IE00B031HY20.USD","LU1328277881.USD","BK1521","LU1008478684.HKD","LU1807302812.USD","LU1226288170.HKD","LU0501845795.SGD","LU0315179316.USD","IE0008369823.USD","LU1960683339.HKD","IE00BZ08YR35.GBP","LU1226287529.USD","LU1813983027.USD","LU0326950275.SGD","LU1951186391.HKD","LU0140636845.USD","IE00BZ08YS42.EUR","LU1226287792.SGD","HK0000165453.HKD","LU2039709279.SGD","LU1226288253.USD","01093","KURE","LU1226287875.USD","LU0067412154.USD","LU0314109678.HKD","SG9999004220.SGD","BK1515","LU1152091754.HKD","LU1993786604.SGD","IE00B543WZ88.USD","BK1191","IE0008368742.USD","IE00B5MMRT66.SGD","LU1152091168.USD","IE00BZ08YT58.USD","LU0880133367.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658475981","title":"Innovent Biologics Schedules Board Meeting to Review Interim Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2658475981","media":"Reuters","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658475981?lang=en_us&edition=fundamental","pubTime":"2026-08-10 17:05","pubTimestamp":1786352720,"startTime":"0","endTime":"0","summary":"Innovent Biologics schedules board meeting to review interim resultsInnovent Biologics set a board meeting for Aug. 25, 2026 to review interim results for the six months ended June 30, 2026.Disclaimer","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260810:nNDLbzWXSb:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0455707207.USD","01801","KURE","LU2097828631.EUR","BK1583","LU2242644610.SGD","LU0463099449.HKD","LU1969619763.USD","LU2097828805.USD","LU2488822045.USD","LU0326950275.SGD","LU1188198961.HKD","01911","BK1147","LU0244354667.USD","BK1589","LU2097828714.EUR","LU2097828557.USD","LU2328871848.SGD","BK1161","LU0502904849.HKD","LU2097828474.EUR","HK0000165453.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1157613829","title":"Innovent Biologics Slashes Prices on Weight-Loss Drug as Growth Concerns Mount","url":"https://stock-news.laohu8.com/highlight/detail?id=1157613829","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1157613829?lang=en_us&edition=fundamental","pubTime":"2026-08-10 16:10","pubTimestamp":1786349446,"startTime":"0","endTime":"0","summary":"Innovent Biologics (01801.HK) has delivered a surprisingly strong financial performance for the first half of 2026. On August 5, the company reported product sales revenue surging over 55%...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1188198961.HKD","BK1583","LU0326950275.SGD","LU2097828474.EUR","BK1161","KURE","LU2097828631.EUR","LU2097828805.USD","LU2097828557.USD","LU2242644610.SGD","BK1589","01801","LU1969619763.USD","LU2097828714.EUR","LU0502904849.HKD","LU2328871848.SGD","LU2488822045.USD","LU0244354667.USD","HK0000165453.HKD","LU0455707207.USD","LU0463099449.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658602868","title":"Akeso Doses First Patient in Phase II Trial of Ak146d1 ADC Plus Ivonescimab in Advanced Breast Cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2658602868","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658602868?lang=en_us&edition=fundamental","pubTime":"2026-08-10 12:07","pubTimestamp":1786334823,"startTime":"0","endTime":"0","summary":"Akeso doses first patient in Phase II trial of AK146D1 ADC plus ivonescimab in advanced breast cancerAkeso dosed the first patient in a Phase II study of TROP2/Nectin-4 bispecific ADC AK146D1 combined","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260810:nNDLc1w1yj:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B5MMRT66.SGD","LU0417516571.SGD","LU0634319403.HKD","BK1574","IE00BPRC5H50.USD","LU1794554557.SGD","LU1720050803.USD","LU2399975544.HKD","LU0348735423.USD","LU2778985437.USD","KURE","LU0348766576.USD","LU0348767384.USD","LU2476274720.SGD","LU0348784397.USD","BK1161","IE00B543WZ88.USD","LU0561508036.HKD","LU1961090484.USD","LU0348825331.USD","LU0348827113.USD","LU0540923850.HKD","LU0348783233.USD","LU2476274308.USD","09926","LU0417516738.SGD","LU2488822045.USD","LU0417516902.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658460283","title":"Akeso Advances IO2.0 + Adc2.0 Strategy: First Patient Dosed in Phase Ii Study of Trop2/Nectin-4 Bispecific ADC (Ak146d1) Combined with Ivonescimab in Breast Cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2658460283","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658460283?lang=en_us&edition=fundamental","pubTime":"2026-08-10 12:06","pubTimestamp":1786334787,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260810:nTUA5SMJJP:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU0540923850.HKD","LU2778985437.USD","LU0417516738.SGD","LU2476274720.SGD","LU2399975544.HKD","IE00BPRC5H50.USD","LU1961090484.USD","LU0561508036.HKD","09926","IE00B5MMRT66.SGD","BK1161","LU1794554557.SGD","LU0348827113.USD","LU1720050803.USD","KURE","BK1574","LU2488822045.USD","LU0417516902.SGD","LU0634319403.HKD","IE00B543WZ88.USD","LU0348825331.USD","LU2476274308.USD","LU0348784397.USD","LU0348735423.USD","LU0417516571.SGD","LU0348783233.USD","LU0348766576.USD","LU0348767384.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1175410099","title":"BOCOM International Lifts BEONE MEDICINES Price Target to HKD 276, Maintains Buy Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=1175410099","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1175410099?lang=en_us&edition=fundamental","pubTime":"2026-08-10 11:08","pubTimestamp":1786331293,"startTime":"0","endTime":"0","summary":"BOCOM International has released a research report raising its price target for BEONE MEDICINES (06160) from HKD 229.2 to HKD 276, while maintaining a \"Buy\" rating.In the second quarter, Zanubutinib...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","BK4588","LU0228659784.USD","LU1719994722.HKD","LU2328871848.SGD","BK1161","ONC","BK0239","BK1583","BK4139","LU1303224171.USD","LU0307460666.USD","LU0828237510.HKD","LU1969619763.USD","LU0588546209.SGD","EWH","LU1770034418.SGD","KURE","06160","LU1251922891.USD","BK4526","BK1500","688235","BK1588"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":10,"totalSize":200,"code":"91000000","status":"200"}]}}